Liberty Health Sciences (OTCMKTS:LHSIF) Stock Price Down 2.2% – Should You Sell?

Liberty Health Sciences Inc. (OTCMKTS:LHSIFGet Free Report) was down 2.2% during mid-day trading on Tuesday . The company traded as low as $1.10 and last traded at $1.1446. Approximately 671,400 shares traded hands during mid-day trading, a decline of 60% from the average daily volume of 1,668,884 shares. The stock had previously closed at $1.17.

Liberty Health Sciences Stock Down 2.2%

The stock’s 50-day simple moving average is $1.14 and its 200 day simple moving average is $1.14. The firm has a market cap of $392.01 million, a P/E ratio of 38.17 and a beta of 1.70.

Liberty Health Sciences Company Profile

(Get Free Report)

Liberty Health Sciences, trading on the OTC Markets under the symbol LHSIF, is a vertically integrated medical cannabis company headquartered in Florida. The company holds state‐issued Medical Marijuana Treatment Center licenses that authorize cultivation, processing and retail operations within Florida’s regulated medical marijuana program. Its state‐of‐the‐art cultivation facilities feature controlled indoor and greenhouse environments designed to produce consistent, high‐quality flower and derivative products.

Liberty Health Sciences markets its products under the Sunshine Cannabis Co brand, offering a range of cannabis formulations that include dried flower, pre-rolled joints, concentrates, oils, capsules and topical preparations.

Further Reading

Receive News & Ratings for Liberty Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.